Specialities

Specialities

Allergic Conditions
Alopecia Areata
Atopic Dermatitis
Axial Spondyloarthritis
Immuno-oncology
COVID-19
Dermatological Conditions
Fibromyalgia
Digestive Disorders
Gout
Cardiovascular Conditions
Liver Disorders
Immunology
Paediatric Rheumatology
Neurological Disorders
Osteoarthritis
Primary Immunodeficiencies
Psoriasis
Psoriatic Arthritis
Respiratory Disorders
Rare Autoimmune Diseases
Rheumatic Diseases
Rheumatoid Arthritis
Sarcoidosis
Sjögren’s Syndrome
Systemic Lupus Erythematosus
Systemic Sclerosis
Autoimmune Endocrine Disorders
Vitiligo
Vasculitis
Vaccinology
Celiac Disease
Haematological Disorders
Hidradenitis Suppurativa
Inflammatory Bowel Disease
Musculoskeletal Diseases
Paediatric Dermatology
Paediatric Gastroenterology
Transplant Immunology
Urticaria
Search

Trending Topic
2 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Foreword – touchREVIEWS in RMD, Volume 4, Issue 1, 2025

From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In this latest edition of touchREVIEWS in RMD, we’re excited to present a collection […]

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Search Results

Showing Results for humans

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

Clinical Approach to the Care of Patients with Immune Checkpoint Inhibitor-associated Inflammatory Arthritis

Madalyn Walsh, Petar S Lenert, Jennifer Strouse

The use of immune checkpoint inhibitors (ICIs) in treating cancer has greatly improved survival outcomes, particularly in patients with advanced disease for whom successful treatment options have previously been limited. For example, in patients with metastatic melanoma, the median survival ...

touchREVIEWS in RMD. 2025;4(1):11–14
Mark CompleteCompleted
BookmarkBookmarked

CAR T Cell Therapy: A New Hope for Refractory Lupus?

Michael Alsharkawy, Alice Mason, May Lwin

Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disorder affecting skin, joints, kidneys, the heart, lungs, the brain and blood cells, and is characterized by heterogeneous presentations and severity. It is more common in females than males, with a ratio ...

touchREVIEWS in RMD. 2024;3(1):13–20
Mark CompleteCompleted
BookmarkBookmarked

The Complement System in Spondyloarthritis: What Do We Know?

Clara Elbæk Mistegaard, Fabian Proft

The term spondyloarthritis (SpA) encompasses a number of disease entities that share common clinical, biological and genetic characteristics. Common clinical features include inflammation in the axial skeleton, including the spine and sacroiliac joints, and inflammation of peripheral musculoskeletal structures such ...

touchREVIEWS in RMD. 2022;2(1):50–6 DOI: https://doi.org/10.17925/RMD.2022.1.2.50
Mark CompleteCompleted
BookmarkBookmarked

Avacopan: An Oral Complement 5a Inhibitor for ANCA-associated Vasculitis

Matthew J Mandell, Gatr-Alnada Gheriani, Aleksander Lenert

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) includes several distinct clinical entities: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA) and renal-limited vasculitis. What all these diseases have in common is the presence of serum autoantibodies, ...

touchREVIEWS in RMD 2022;1(1):23–8 DOI: https://doi.org/10.17925/RMD.2022.1.1.23

Latest articles videos and clinical updates - straight to your inbox

Close Popup